#RSV #RSVVaccine
Early in May, the US FDA approved the first respiratory syncytial virus (RSV) vaccine for use in people 60 and older in the US. So, let’s find out what RSV is. What is so special about this virus is that it has taken more than 50 years to develop a vaccine.
If you appreciate my work, you can buy me a coffee. :)
[ Ссылка ]
Disclaimer:
This video is Dr. Hong’s interpretation and summary of publicly available scientific information.
This video is not intended to serve as any advice regarding the treatment, prevention, and diagnosis of any diseases.
Dr. Hong has no connections and receives no monetary compensation from any pharmaceutical companies or the government.
This video is for educational purposes only.
-------------------------------
To learn more:
Dr. Hong's Biotechnology Lecture 01: Overview of Biotechnology
[ Ссылка ]
Dr. Hong's Immunology Lecture 12: Immunological Memory and Vaccines
[ Ссылка ]
Dr. Hong's Immunology Lecture 11: Immune Failure
[ Ссылка ]
-------------------------------
Source References:
Respiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and Treatment
[ Ссылка ]
Respiratory syncytial virus entry and how to block it
[ Ссылка ]
Immune responses and disease enhancement during respiratory syncytial virus infection
[ Ссылка ]
RSV in Older Adults and Adults with Chronic Medical Conditions
[ Ссылка ]
Respiratory syncytial virus infection in elderly and high-risk adults
[ Ссылка ]
Respiratory syncytial virus and other respiratory viral infections in older adults with moderate to severe influenza-like illness
[ Ссылка ]
The race to make vaccines for a dangerous respiratory virus
[ Ссылка ]
Vaccine-Associated Enhanced Viral Disease: Implications for Viral Vaccine Development
[ Ссылка ]
A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism
[ Ссылка ]
Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults (Phase III Clinical Trials)
[ Ссылка ]
Arexvy Prescribing Information
[ Ссылка ]
Ещё видео!